Upgrade to begin using 40 years of financial statements and get so much more. Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for an IPO to fund development of vaccines that could compete with ...

Xilio Ther­a­peu­tics said its an­ti-CT­LA-4 pro­duced promis­ing ini­tial da­ta in cer­tain col­orec­tal can­cer pa­tients en­rolled in a mid-stage tri­al. But the drug’s fu ...

Plus, news about Rivus and Crown Labs: Two Chi­nese biotechs file for stock list­ings in Hong Kong: Shang­hai Bao Phar­ma­ceu­ti­cals and Sichuan Biokin Phar­ma­ceu­ti­cal join … ...

It acts by targeting programmed cell death protein 1 (PD1) and cytotoxic T lymphocyte protein 4 (CTLA4). Systimmune, a subsidiary of Sichuan Biokin Pharmaceutical Co Ltd, is a biopharmaceutical ...

New York, USA, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Advancements in Ocular Hypertension Clinical Trial Pipeline as 60+ Companies Pave the Way for Future Solutions | DelveInsight The ocular ...

New York, USA, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Advancements in Ocular Hypertension Clinical Trial Pipeline as 60+ Companies Pave the Way for Future Solutions | DelveInsight The ocular hypertension ...

Ibotta (NYSE: IBTA) landed at No. 10 on the PitchBook list. Ahead of it were companies like SystImmune Inc., a Redmund, Washington-based biotechnology company with an $8.4 billion exit via an ...

Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial Over the past 15 years, the landscape ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With these agreements, the respective parties will work to advance therapeutic candidates for treating fibrotic diseases, osteoarthritis, and Alzheimer’s disease.